This includes: Monitoring B12 levels every 36 months Addressing underlying conditions (IBD, EPI, dysbiosis, etc.) Ongoing dietary support with a complete, gut-friendly meal plan Routine gut support including probiotics, fibre, and deworming Case Example: Giant Schnauzer with Imerslund-Grsbeck Syndrome A 6-month-old Giant Schnauzer presented with poor weight gain, chronic diarrhoea, and low energy
So, AOD 9604 should be viewed as a tool for studying metabolism, not as a weight loss treatment
Preclinical and clinical studies have demonstrated its efficacy in reducing body weight both as a monotherapy and in combination with GLP-1 receptor agonists such as semaglutide, highlighting its potential as a next-generation therapeutic agent for obesity and metabolic syndrome management
Scientific Background on TB-500 (Thymosin Beta-4 Fragment) TB-500 is the synthetic heptapeptide fragment (Ac-LKKTETQ-NH) of the naturally occurring 43-amino-acid protein Thymosin Beta-4 (T4)
